MDR multidrug resistance
MDR (multidrug resistance) is a property that first identified in tumor cell, hat the resistance of tumor cell is to a variety of chemotherapy agent due to active efflux via transporter proteins.
Products for MDR multidrug resistance
- Cat.No. Product Name Information
-
GC45246
(-)-Chaetominine
(-)-Chaetominine
(-)-Chaetominine is a cytotoxic alkaloid originally isolated from Chaetomium sp. -
GC41865
10'-Desmethoxystreptonigrin
10'-Desmethoxystreptonigrin is an antibiotic originally isolated from Streptomyces and a derivative of the antibiotic streptonigrin.
-
GC45324
2,5-dimethyl Celecoxib
DMC
-
GC91154
33-BCRP Inhibitor
A BCRP inhibitor
-
GC91135
4-(3,4-Difluorobenzo)curcumin
A semisynthetic coumarin with antiparasitic and anticancer activities
-
GC42616
7-oxo Staurosporine
BMY 41950, RK-1409
7-oxo Staurosporine is an antibiotic originally isolated from S.
-
GC49275
8-Oxycoptisine
8-Oxocoptisine
8-Oxycoptisine is a natural protoberberine alkaloid with anti-cancer activity. -
GC46809
Afatinib-d6
BIBW 2992 D6
An internal standard for the quantification of afatinib -
GC42806
Andrastin A
NSC 697452
Andrastin A is a meroterpenoid farnesyltransferase inhibitor. -
GC43004
C10 Ceramide (d18:1/10:0)
N-decanoyl-D-erythro-Sphingosine
C10 ceramide is an endogenous, bioactive sphingolipid produced by ceramide synthase.
-
GC43060
C2 Adamantanyl Globotriaosylceramide (d18:1/2:0)
C2 Adamantanyl globotriaosylceramide (AdaGb3) is a bioactive sphingolipid and water-soluble form of globotriaosylceramide that contains an adamantanyl group in place of the fatty acyl chain.
-
GC45395
Cabazitaxel-d9
XRP6258-d9; RPR-116258A-d9; taxoid XRP6258-d9
Cabazitaxel-d9 is deuterium labeled Cabazitaxel. Cabazitaxel is a semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity. -
GC45679
Carubicin
Antibiotic R 588A, Carminomycin, NCI 180024, NSC 180024
An anthracycline with anticancer activity -
GC40795
CAY10503
CAY10503 is a proapoptotic, antiproliferative compound that is able to arrest cell cycle progression in the G0-G1 phase.
-
GC18901
CAY10647
CAY10647 is an aryl-benzoyl-imidazole which prevents proliferation of multidrug resistant cancer cells in vitro (IC50 = 28-63 nM) and inhibits melanoma xenograph tumor growth in vivo (10-30 mg/kg).
-
GC45792
Chlorido[N,N'-disalicylidene-1,2-phenylenediamine]iron(III)
Iron Salophene Complex, N,N'-o-Phenylenebis(salicylideneaminato)iron(III) Chloride
An inducer of ferroptosis -
GC90543
EGFR Peptide (human, mouse) (myristoylated) (trifluoroacetate salt)
A PKC inhibitor
-
GC46004
Evoxanthine
NSC 407812
An alkaloid -
GC91152
Flavokawain 1i
A flavokawain derivative with anticancer and antiviral activities
-
GC90660
Fz25
A triazole-modified sterol and an anticancer agent
-
GC49106
Gentisein
NSC 329491
A xanthone with diverse biological activities -
GC47409
Glycocholic Acid-d4
Cholylglycine-d4, GCA-d4
A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications -
GC91057
HP661
A mitochondrial complex I inhibitor
-
GC91403
HR68
PP21
HR68 is an anticancer agent and a derivative of the peroxisome proliferator-activated receptor (PPAR) agonist fenofibric acid . -
GC49670
Indium (III) thiosemicarbazone 5b
An anticancer agent
-
GC44129
MC 70
A P-glycoprotein inhibitor
-
GC48479
Migrastatin
(+)-Migrastatin
A fungal metabolite with antimuscarinic and anticancer activities -
GC44195
Milbemycin A4 oxime
5-Ketomilbemycin A4 oxime, 5-Oxomilbemycin A4 5-oxime
Milbemycin A4 oxime is a derivative of milbemycin A4 and a component of milbemycin oxime, compounds that both have insecticidal and nematocidal activity. -
GC41564
MPT0B014
An inhibitor of tubulin polymerization
-
GC19270
Olmutinib
Olmutinib (HM61713; BI-1482694) is an irreversible EGFR tyrosine kinase inhibitor that binds to a cysteine residue near the kinase domain.
-
GC45784
ONT-093
OC 144093
A P-glycoprotein inhibitor -
GC49251
Oxaliplatin-d10
Lipoxal-d10
An internal standard for the quantification of oxaliplatin -
GC44613
PF-6274484
PF-6274484 is an inhibitor of the EGF receptor (EGFR; IC50s = 0.18 and 0.14 nM for wild-type EGFR and inhibitor-resistant EGFRL858R/T790M, respectively).
-
GC44615
PGP-4008
PGP-4008 is a selective inhibitor of P-glycoprotein (P-gp) that does not affect the activity of multidrug resistance-related protein 1 (MRP1).
-
GC41629
Piperafizine A
Piperafizine A is a natural methylated diketopiperazine first isolated from an actinomycete, Streptoverticillium.
-
GC52455
Pixantrone-d8 (maleate)
An internal standard for the quantification of pixantrone
-
GC52104
Ponatinib (hydrochloride)
AP 24534
An inhibitor of native and mutant Bcr-Abl -
GC17403
Pyronaridine Tetraphosphate
PND
An antimalarial agent
-
GC44821
Reversin 121
Reversin 121 is a hydrophobic peptide chemosensitizer that can reverse P-glycoprotein-mediated multidrug resistance.
-
GC91096
S-72
An inhibitor of microtubule polymerization
-
GC45688
STX140
2-Methoxyestradiol-bis-sulphamate
An estrogen sulfamate -
GC48119
Suprafenacine
SML1493
An inhibitor of tubulin polymerization with anticancer activity -
GC48219
Ulipristal Acetate-d6
CDB-2914-d6
An internal standard for the quantification of ulipristal acetate -
GC49308
Ungeremine
Lycobetaine
A betaine-type alkaloid with diverse biological activities -
GC91435
YCH1899
YCH1899 is an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1) and PARP2 (IC50s = 1 It is selective for PARP1 and PARP2 over PARP3, -4, -5A, -5B, -6, -7, -10, and -12 (IC50s = 1-14.1 nM).